DE602007009213D1 - är Ammoniumhalogenide - Google Patents

är Ammoniumhalogenide

Info

Publication number
DE602007009213D1
DE602007009213D1 DE602007009213T DE602007009213T DE602007009213D1 DE 602007009213 D1 DE602007009213 D1 DE 602007009213D1 DE 602007009213 T DE602007009213 T DE 602007009213T DE 602007009213 T DE602007009213 T DE 602007009213T DE 602007009213 D1 DE602007009213 D1 DE 602007009213D1
Authority
DE
Germany
Prior art keywords
ammonium halides
inflammation
eye
prevention
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007009213T
Other languages
English (en)
Inventor
Gregory Lambert
Laura Rabinovich-Guilatt
Frederic Lallemand
Jean-Sebastien Garrigue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novagali SA
Original Assignee
Novagali SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novagali SA filed Critical Novagali SA
Publication of DE602007009213D1 publication Critical patent/DE602007009213D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
DE602007009213T 2007-07-09 2007-07-09 är Ammoniumhalogenide Active DE602007009213D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07112104A EP2016936B1 (de) 2007-07-09 2007-07-09 Öl in Wasser Emulsionen enthaltend NSAID und quartär Ammoniumhalogenide

Publications (1)

Publication Number Publication Date
DE602007009213D1 true DE602007009213D1 (de) 2010-10-28

Family

ID=38686708

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007009213T Active DE602007009213D1 (de) 2007-07-09 2007-07-09 är Ammoniumhalogenide

Country Status (4)

Country Link
EP (1) EP2016936B1 (de)
AT (1) ATE481087T1 (de)
DE (1) DE602007009213D1 (de)
ES (1) ES2352296T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT105982B (pt) * 2011-11-03 2014-07-29 Laboratório Edol Produtos Farmac Uticos S A Composição e método de preparação a frio de uma emulsão utilizada como veículo de fármacos anti-inflamatórios
EP3013790A1 (de) 2013-06-27 2016-05-04 Mylan Laboratories Ltd. Verfahren zur herstellung von nepafenac
CA3195291A1 (en) * 2022-04-13 2023-10-13 Caravel Therapeutics, Inc. Preservative-free ophthalmic pharmaceutical emulsion and its application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
ES2094688B1 (es) * 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US6552020B1 (en) * 1999-07-30 2003-04-22 Allergan, Inc. Compositions including antibiotics and methods for using same
CN101282714B (zh) * 2005-10-10 2012-12-12 诺瓦加利制药公司 包含***素的眼用乳剂

Also Published As

Publication number Publication date
EP2016936B1 (de) 2010-09-15
ES2352296T3 (es) 2011-02-17
ATE481087T1 (de) 2010-10-15
EP2016936A1 (de) 2009-01-21

Similar Documents

Publication Publication Date Title
CY1122687T1 (el) Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συναρμογης σε ενα υποκειμενο
CY1124144T1 (el) Συνθεσεις και μεθοδοι για θεραπεια εγκεφαλικου επεισοδιου σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
CY1123833T1 (el) Μεθοδοι προληψης καρδιαγγειακων συμβαντων σε δυσλιπιδαιμικους πληθυσμους υπολειπομενου κινδυνου
CL2010001406A1 (es) Composicion farmaceutica oftalmica que comprende povidona yodada, y un compuesto antiinflamatorio esteroidal, un compuesto antiinflamatorio no esteroidal, un antibacteriano, un antialergico o un compuesto antiglaucoma; y metodo para preservar la composicion.
CY1110606T1 (el) Χρηση των ανταγωνιστων της il-23 και il-17 για τη θεραπεια της αυτοανοσης οφθαλμικης φλεγμονωδους νοσου
MD3880197T2 (ro) Metode de tratament pentru fibroză chistică
BRPI0821543A2 (pt) Lente intraocular, e, lente oftálmica difrativa
NO20052751D0 (no) Oftalmisk preparat for behandling av okulaer hypertensjon.
BRPI0814957A2 (pt) Composto, pró-droga, agente farmacêutico, método para a profilaxia ou tratamento de uma doença, distúrbio ou condição, e, uso do composto.
MD3347002T2 (ro) Tratamentul bolii Alzheimer într-o populație specifică de pacienți
BR0300035B1 (pt) sistema para otimizar uma prescriÇço para um tratamento refrativo.
NL2003152A1 (nl) Radiation source, lithographic apparatus and device manufacturing method.
ATE429921T1 (de) 9a-carbamoyl- und thiocarbamoylazalide mit antimalariawirkung
DE602007009213D1 (de) är Ammoniumhalogenide
ATE531715T1 (de) 1,3-dihydro-2h-pyrroloä3.2-büpyridin-2-onderiva e,deren herstellung und deren therapeutische verwendungen
BRPI0809918A2 (pt) Método para formar poliuretanos termoplásticos em uma lente óptica, e, lente oftálmica.
WO2009007409A3 (en) Oil in water emulsion comprising nsaids and quaternary ammonium halides
AR053046A1 (es) Cristal de derivado de aminonopirrolidina y metodo de produccion del mismo
ITRM20040223A1 (it) Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.
DE60333801D1 (de) Kollimator, röntgenstrahler und röntgengerät
EA200900923A1 (ru) Применение нейропротективных соединений в получении лекарственных средств, предназначенных для лечения нейродегенеративных заболеваний
DE60308240D1 (de) Laser-Augenbehandlungs-Einrichtung
JPWO2020222195A5 (de)
CY1112336T1 (el) Ιατρικη χρηση του οξινου φουμαρικου και δισοξινου φωσφορικου προπιονικου 3-(2,2,2-τριμεθυλυδραζινιου)
RU2007103667A (ru) Способ лечения псориаза